NASDAQ: VRDN Viridian Therapeutics, Inc.\DE 8-K

Viridian raises $359M through equity and convertible debt to repay loans, fund R&D expansion

Filed May 11, 2026 · Period ending May 6, 2026 · ~1 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade VRDN commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 1, 2026 8:12 PM